|
|
 |
|
| |
The application of modern high-throughput screening (HTS) techniques in drug discovery led to increasing brick dust candidates which had to be developed by formulation scientist. Novel drug delivery technologies have been playing a significant role in enhancing solubility and bioavailability, as well as formulation development. Innovative drug delivery systems also provide solutions for burgeoning biologics which by their nature are difficult to administer. Advanced drug delivery systems are not only revolutionizing the development of protein, vaccine and insulin drugs but also shaping new RNAi and targeted cancer therapies.
Facing patent cliff, many research-based pharmaceutical companies are utilizing novel drug delivery technologies to maximizing successful drug patent lives.
With more and more Asian pharmaceutical companies, mostly in China and India, getting involved in formulation development, it has become a strategic issue that decides the future development of a company as to how to promote formulation development and corporate development through innovative DDS technologies and new strategies for formulation development.
DDF Asia Summit 2011 is dedicated to enhancing drug delivery innovation and cooperation, facilitating formulation development by providing a unique platform for Research- based Pharmaceutical Companies, CROs, DDS Innovators and Lab Instrument Manufacturers.
Why Should You Attend?
Build DDS & Formulation development partnership to expedite your R&D process
Explore innovative approaches to enhance solubility, dissolution and bioavailability
Facilitate formulation development with innovation and experience sharing
Develop innovative drug delivery systems to deliver bio products
Understand future trends of DDS and Formulation Development
Network with leaders from the pharma, biotech, device and drug delivery industries
more>> |
|
| |
|
|
 |
|
| |
 |
Jack Aurora
Chief Scientific Officer, Generic Drugs
Hisun Pharma |
|
 |
Alex Fowkes
Former Executive Director,Head of R&D Business Devlopment
Pfizer |
|
| |
|
|
| |
 |
Maria Xuemei Song
President
Venturepharm Service Group |
|
 |
Vincent Li
Senior Director, PRD & CTM Manufacturing Services
Frontage laboratories |
|
| |
|
|
| |
 |
Tomas Landh
Director Strategy and Sourcing
Novo Nordisk |
|
 |
Guang Cheng
Vice President,
Nanjing Luye Sike Pharmaceutical |
|
| |
|
|
| |
 |
Patrick Crowley
Founder of Callum Pharmaceutical Consultancy
Former VP in Pharmaceutical Development GSK
|
|
 |
Richard Kenley
CEO
Advantar Laboratories |
|
| |
|
|
| |
 |
Celal Albayrak
CEO
Alrise Biosystems |
|
 |
James Patterson
Formulation Technical Project Leader
Center of Innovation, GSK |
|
| |
|
|
| |
 |
Sven Stegemann
Director Pharmaceutical Business Development
Capsugel |
|
 |
Chunsheng Gao
Professor, Institute of Toxicology & Pharmacology
Academy of Military Medical Sciences |
|
| |
|
|
| |
 |
Yongda Sun
Professor
Tianjin University |
|
 |
Peter York
Chief Scientist
CrystecPharma |
|
| |
|
more>> |
|
|
|
| |
 |
| |
|
|
| |
 |
|
Drug Delivery & Formulation Asia Summit 2011 | Copyright © 2011 SISC International Ltd, All rights reserved
For more information, please contact T：+86 21 6052 0431 F：+86 21 6380 0607 E：luke.xia@s-isc.com |
|
|
|
